224 related articles for article (PubMed ID: 22551)
1. The inhibition by 6-diazo-5-oxo-l-norleucine of glutamine catabolism of the cultured human lymphoblast.
Willis RC; Seegmiller JE
J Cell Physiol; 1977 Dec; 93(3):375-82. PubMed ID: 22551
[TBL] [Abstract][Full Text] [Related]
2. [Inactivation of microbial glutamin-(asparagin-)ase by azaserine and 6-diazo-5-oxo-L-norleucine].
Lebedeva ZI; Kabanova EA; Berezov TT
Biull Eksp Biol Med; 1985 Dec; 100(12):696-8. PubMed ID: 4074870
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of antitumor activity of glutamine antagonists 6-diazo-5-oxo-L-norleucine and acivicin in cell culture by glutaminase-asparaginase.
Rosenfeld H; Roberts J
Cancer Res; 1981 Apr; 41(4):1324-8. PubMed ID: 7214322
[TBL] [Abstract][Full Text] [Related]
4. 6-diazo-5-oxo-L-norleucine and azaserine as affinity inhibitors of glutamin(asparagin)ase.
Lebedeva ZI; Kabanova EA; Berezov TT
Biochem Int; 1986 Mar; 12(3):413-20. PubMed ID: 3707592
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of rat renal phosphate-dependent glutaminase with 6-diazo-5-oxo-L-norleucine. Evidence for interaction at the glutamine binding site.
Shapiro RA; Clark VM; Curthoys NP
J Biol Chem; 1979 Apr; 254(8):2835-8. PubMed ID: 429321
[TBL] [Abstract][Full Text] [Related]
6. Antiviral effect of 6-diazo-5-oxo-L-norleucine, antagonist of gamma-glutamyl transpeptidase, on replication of human parainfluenza virus type 2.
Nishio M; Tsurudome M; Bando H; Komada H; Ito Y
J Gen Virol; 1990 Jan; 71 ( Pt 1)():61-7. PubMed ID: 1968085
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of 6-diazo-5-oxo-L-norleucine and N-[N-gamma-glutamyl-6-diazo-5-oxo-norleucinyl]-6-diazo-5-oxo-norleucine against experimental tumors in conventional and nude mice.
Ovejera AA; Houchens DP; Catane R; Sheridan MA; Muggia FM
Cancer Res; 1979 Aug; 39(8):3220-4. PubMed ID: 572261
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of glutamine in erythrocytes infected with the human malaria parasite: Plasmodium falciparum.
Vilmont M; Azoulay M; Frappier F
Ann Parasitol Hum Comp; 1990; 65(4):162-6. PubMed ID: 1982204
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of a mutant Chinese hamster cell line resistant to the glutamine analog 6-diazo-5-oxo-L-norleucine.
Kaufman ER
Somat Cell Mol Genet; 1985 Jan; 11(1):1-10. PubMed ID: 3856328
[TBL] [Abstract][Full Text] [Related]
10. Effect of 6-diazo-5-oxo-L-norleucine (DON) on human carcinoid tumor cell aggregates.
Wu F; Bergström M; Stridsberg M; Orlefors H; Eriksson B; Oberg K; Watanabe Y; Långstrom B
Anticancer Res; 1997; 17(4A):2363-7. PubMed ID: 9252648
[TBL] [Abstract][Full Text] [Related]
11. Glutamine in the mechanism of ammonia-induced astrocyte swelling.
Jayakumar AR; Rao KV; Murthy ChR; Norenberg MD
Neurochem Int; 2006; 48(6-7):623-8. PubMed ID: 16517020
[TBL] [Abstract][Full Text] [Related]
12. Discriminative effect of gamma-glutamyl transpeptidase inhibitors on metabolism of leukotriene C4 in peritoneal cells.
Aharony D; Dobson P
Life Sci; 1984 Nov; 35(21):2135-42. PubMed ID: 6149445
[TBL] [Abstract][Full Text] [Related]
13. Affinity labeling of gamma-glutamyl transpeptidase and location of the gamma-glutamyl binding site on the light subunit.
Tate SS; Meister A
Proc Natl Acad Sci U S A; 1977 Mar; 74(3):931-5. PubMed ID: 15260
[TBL] [Abstract][Full Text] [Related]
14. Limb development in mouse embryos: protection against teratogenic effects of 6-diazo-5-ox-L-norleucine (DON) in vivo and in vitro.
Greene RM; Kochhar DM
J Embryol Exp Morphol; 1975 Apr; 33(2):355-70. PubMed ID: 1176851
[TBL] [Abstract][Full Text] [Related]
15. Macrophage-mediated lysis of a beta-cell line, tumour necrosis factor-alpha release from bacillus Calmette-Guérin (BCG)-activated murine macrophages and interleukin-8 release from human monocytes are dependent on extracellular glutamine concentration and glutamine metabolism.
Murphy C; Newsholme P
Clin Sci (Lond); 1999 Jan; 96(1):89-97. PubMed ID: 9857111
[TBL] [Abstract][Full Text] [Related]
16. Glutamine metabolism in bone.
Biltz RM; Letteri JM; Pellegrino ED; Palekar A; Pinkus LM
Miner Electrolyte Metab; 1983; 9(3):125-31. PubMed ID: 6135980
[TBL] [Abstract][Full Text] [Related]
17. Glutaminase inhibition and the release of neurotransmitter glutamate from synaptosomes.
Bradford HF; Ward HK; Foley P
Brain Res; 1989 Jan; 476(1):29-34. PubMed ID: 2563333
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of renal gamma-glutamyl transferase by 6-diazo-5-oxo-L-norleucylglycine, an inactive precursor of affinity-labeling reagent.
Inoue M; Morino Y
Proc Natl Acad Sci U S A; 1981 Jan; 78(1):46-9. PubMed ID: 6113588
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic mechanisms of glutamine antagonists in mouse L1210 leukemia.
Lyons SD; Sant ME; Christopherson RI
J Biol Chem; 1990 Jul; 265(19):11377-81. PubMed ID: 2358467
[TBL] [Abstract][Full Text] [Related]
20. Glutamine as a precursor for transmitter glutamate, aspartate and GABA in the cerebellum: a role for phosphate-activated glutaminase.
Holten AT; Gundersen V
J Neurochem; 2008 Feb; 104(4):1032-42. PubMed ID: 17986214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]